Prolintane

Jump to: navigation, search

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];

Aditya Govindavarjhulla, M.B.B.S. [2]

Prolintane
Prolintane Wiki Str.png
Clinical data
ATC code
Identifiers
CAS Number
PubChem CID
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC15H23N
Molar mass217.35 g/mol

Overview

Prolintane (Promotil, Katovit) is a psychostimulant/nootropic.

Prolintane is a stimulant closely related in structure to other drugs such as pyrovalerone and presumably has a similar mechanism of action, by inhibiting the reuptake of dopamine and other monoamine neurotransmitters. Prolintane is a mild stimulant with a good safety profile and relatively low incidence of cardiovascular problems or other side effects such as anorexia and insomnia, although these side effects may still occur at higher doses. However the good safety profile of this drug at low doses makes it suitable for use in elderly people to increase motivation and counteract the effects of senile dementia and age-related cognitive decline. It is mainly used in European countries.

Side effects

  • Loss of appetite
  • Weight loss
  • Headache
  • Dry mouth
  • Skin rash
  • Sweating
  • Ringing in the ears
  • Shakiness and nervousness
  • Stomach pain
  • Agitation
  • Constipation
  • Anxiety Dizziness
  • Trouble sleeping
  • Muscle pain
  • Nausea
  • Tachycardia
  • Sore throat
  • Frequent urination


Withdrawal



Template:Pharmacology-stub


Linked-in.jpg